Benchmarking clinical reasoning and accuracy of large language models on breast oncology multiple-choice questions.

In an interview with Technology Networks, Dr. Daniel Reker discusses how machine learning is improving data-scarce areas of drug discovery.

Among patients with chronic noncancer pain, a novel machine learning model effectively predicts opioid use disorder risk.

The ability to anticipate what comes next has long been a competitive advantage -- one that's increasingly within reach for developers and organizations alike, thanks to modern cloud-based machine ...

Read more about AI-driven learning analytics struggle to deliver measurable gains in higher education on Devdiscourse ...

Waiting for alerts is obsolete — predictive engineering lets cloud systems see trouble coming and fix it before users ever ...

Lithium-ion batteries have become the quiet workhorses of the energy transition, but the way they are designed and tested has ...